TY  - GEN
AU  - Klopp,Ann H
AU  - Moughan,Jennifer
AU  - Portelance,Lorraine
AU  - Miller,Brigitte E
AU  - Salehpour,Mohammad R
AU  - Hildebrandt,Evangeline
AU  - Nuanjing,Jenny
AU  - D'Souza,David
AU  - Souhami,Luis
AU  - Small,William
AU  - Gaur,Rakesh
AU  - Jhingran,Anuja
TI  - Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer
SN  - 1879-355X
PY  - 2013///0611
KW  - Adult
KW  - Aged
KW  - Bone Marrow
KW  - radiation effects
KW  - Cisplatin
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - methods
KW  - Endometrial Neoplasms
KW  - radiotherapy
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Intestine, Small
KW  - Lymphatic Irradiation
KW  - Middle Aged
KW  - Organ Sparing Treatments
KW  - Organs at Risk
KW  - Pelvic Bones
KW  - Pelvis
KW  - Postoperative Care
KW  - Prospective Studies
KW  - Radiation Dosage
KW  - Radiation Injuries
KW  - pathology
KW  - Radiation-Sensitizing Agents
KW  - Radiotherapy, Intensity-Modulated
KW  - adverse effects
KW  - Regression Analysis
KW  - Urinary Bladder
KW  - Uterine Cervical Neoplasms
KW  - drug therapy
KW  - Vagina
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ijrobp.2013.01.017
ER  -